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Background: Mutations in multiple genes have been implicated in familial atrial fibrillation (AF). KCNQ1 was the first disease gene identified for 
familial AF, however, some recent reports showed that potassium channel mutations are not a major cause of AF in the general population. We sought 
to determine the frequency of potassium channel gene mutations in patients with lone AF and characterized the electrophysiological properties of 
the detected mutation.
Methods: We studied 74 patients (54 men, mean age 56 years) with lone AF with a standardized interview, 12-lead ECG, and laboratory studies. 
Onset of AF was 46±12 years old. There were 19 with familial AF and 45 with paroxysmal AF. In these patients, we screened for variants in all exons of 
KCNQ1, KCNH2, KCNE1, KCNE2, KCNJ2 and KCNA5. The potassium currents were analyzed using whole-cell patch clamp technique.
Results: From 74 patients with lone AF, we identified 2 mutations in KCNH2 (T436M and T895M) and 1 mutation in KCNA5 (H463R), which were 
not found in 150 ethnically matched population. The probands with both KCNH2 mutations had a family history of AF, and the proband with KCNA5 
mutation did not. The probands with KCNH2 T895M and KCNA5 H463R showed paroxysamal AF which was refractory to antiarrhythmic drugs. They 
received radiofrequency catheter ablation and maintained a sinus rhythm after the ablation therapy. In contrast, the proband with KCNH2 T436M 
showed permanent AF and received only anticoagulant therapy. Electrophysiological study of both T436M and T895M KCNH2 channels in CHO cells 
showed that peak current density of each mutant channel was significantly bigger than that of WT. Both slow and fast time constants in T436M 
channel were increased significantly compared with WT.
Conclusions: These results demonstrate that KCNH2 and KCNA5 are significant candidate genes for increasing AF susceptibility. In our cohort 
of lone AF patients with family history, 11 % harbored a KCNH2 mutation. Gain-of-function mutations KCNH2 T436M and T895M may predispose 
patients without underlying heart disease to AF, providing new insights into the molecular etiology involved in the pathogenesis of AF.
